These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8111053)

  • 1. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
    Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
    Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.
    Hilliard LM; Williams BF; Lounsbury AE; Howard TH
    Am J Hematol; 1998 Sep; 59(1):28-35. PubMed ID: 9723573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload.
    Singer ST; Quirolo K; Nishi K; Hackney-Stephens E; Evans C; Vichinsky EP
    J Clin Apher; 1999; 14(3):122-5. PubMed ID: 10540366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.
    Adams DM; Schultz WH; Ware RE; Kinney TR
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):46-50. PubMed ID: 8556370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(2):83-97. PubMed ID: 15004333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.
    Savage WJ; Reddoch S; Wolfe J; Casella JF
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):434-6. PubMed ID: 23887022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful long-term erythrocytapheresis therapy in a patient with symptomatic sickle-cell disease using an arterio-venous fistula.
    Hartwig D; Schläger F; Bucsky P; Kirchner H; Schlenke P
    Transfus Med; 2002 Feb; 12(1):75-7. PubMed ID: 11967141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy.
    van Hattem J; Maes P; Esterhuizen TM; Devos A; Ruppert M; van Heerden J
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
    Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
    Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload.
    Dedeken L; Lê PQ; Rozen L; El Kenz H; Huybrechts S; Devalck C; Diallo S; Heijmans C; Ferster A
    Transfusion; 2018 Jun; 58(6):1356-1362. PubMed ID: 29574950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythrocytapheresis on arterial oxygen saturation and hemoglobin oxygen affinity in patients with sickle cell disease.
    Uchida K; Rackoff WR; Ohene-Frempong K; Kim HC; Reilly MP; Asakura T
    Am J Hematol; 1998 Sep; 59(1):5-8. PubMed ID: 9723569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.